Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Clover says its COVID-19 vaccine candidate 67 per cent effective in large trial
The company has a deal to supply up to 414 million doses of its COVID-19 vaccine through the global vaccine sharing scheme COVAX
Industry Knowledge eXchange: Sustainability in Pharma Industry – Leapfrogging into a Carbon Neutral…
22nd September 2021 | 3:30 PM - 5:00 PM IST | Live Webinar
Serum Institute to invest $68 million in Oxford Biomedica
As part of the deal, Serum Life Sciences, a unit of SII, will pick up a 3.9 per cent stake in Oxford Biomedica
Gujarat FDCA launches Ayudmla portal for online drug manufacturing licence for Ayurvedic medicines
Gujarat becomes the first state to launch such initiative towards online licensing, product approvals and digitisation of records
UFlex joins Alliance to end plastic waste to strengthen its global mission of building a circular…
Through this affiliation, UFlex aims to contribute to and guide the Alliance and its members about sustainability practices that…
SII to supply almost 22 crore doses of Covishield vaccine to Centre in October
The Pune-based pharmaceutical company has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month
SCHOTT invests in further melting capacities for pharma glass in India
Investment of 70 million euros will increase capacity by 30 per cent and create 225 new jobs
Lincoln Pharmaceuticals plans to launch Cephalosporin products, acquires plant in Mehsana
The company intends to invest Rs 30 crores in Cephalosporin plant, including capacity expansion and modernisation of the facility
India set to get J&J COVID vaccine doses next month
India's drug regulator last month gave emergency authorisation to the J&J vaccine, whether imported or locally filled and…
Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids
The companies said the vaccine generated an immune response in the five-to-11 year olds in their phase-II/III clinical trial that…